December 2002
Volume 43, Issue 13
ARVO Annual Meeting Abstract  |   December 2002
Intraoperative Mitomycin-C for Severe Stromal Haze After Refractive Surgery
Author Affiliations & Notes
  • PE Demers
    Ophthalmology University of Montreal Montreal PQ Canada
  • Footnotes
    Commercial Relationships   P.E. Demers, None.
Investigative Ophthalmology & Visual Science December 2002, Vol.43, 2110. doi:
  • Views
  • Share
  • Tools
    • Alerts
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      PE Demers; Intraoperative Mitomycin-C for Severe Stromal Haze After Refractive Surgery . Invest. Ophthalmol. Vis. Sci. 2002;43(13):2110.

      Download citation file:

      © ARVO (1962-2015); The Authors (2016-present)

  • Supplements

Abstract: : Purpose:To determine the efficacy of Mitomycin-C (MMC) 0.025% in preventing stromal fibrosis after scar debridement in patients with recalcitrant stromal haze following refractive surgery Methods: Noncomparative case series of 11 eyes in 10 patients who had undergone previous refractive surgery and had developed severe stromal haze. Previous primary refractive surgery included photorefractive keratectomy (PRK) (6 eyes), Lasik (3 eyes) and radial keratotomy (2 eyes). A total of 19 repeat surgical procedures had been done to correct either residual refractive error or haze at the time of presentation. Surgical treatment consisted in epithelial debridement followed by mechanical and/or laser scar removal and intraoperative application of MMC 0.025%. Results: Best-corrected visual acuity (BCVA) improved in all patients. BCVA was calculated in logMAR units. Mean preoperative BCVA was 20/84 (range 20/30-20/200) while mean postoperative BCVA was 20/32 (range 20/20-20/100). The difference between pre and postoperative BCVA was statistically significant (p<0.05). All patients had clearer corneas and had no recurrence of haze throughout the follow-up period (6-18 months). No adverse reactions were noted. Conclusion:Topical intraoperative application of MMC 0.025% may be a successful adjunct to mechanical or laser scar removal in preventing recurrence of severe stromal haze and improve BCVA after complicated corneal refractive surgery.

Keywords: 545 refractive surgery: complications • 552 refractive surgery: PRK • 544 refractive surgery 

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.